Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine plus dexmedetomidine for prevention of postoperative delirium after pediatric neurosurgery
ChiCTR1900024570Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ketamine and dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of postoperative delirium within 5 days. Started Jul 2019; status: recruiting.
02
Drugs
ketaminedexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR1900024570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024570.